Percent free prostate-specific antigen values in men with recurrent prostate cancer after radical prostatectomy

Urology

Volumn 52, Issue 3, 1998, Pages 474-478

  Wojno, Kirk J ^a   Vashi, Apoorva R ^b   Schellhammer, Paul F ^b   Wright Jr , George L ^b   Montie, James E ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; FOLLOW UP; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0032169532     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00209-X     Document Type: Article

References (23)

1. 1. Oesterling JE: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923, 1991.
2. 2. Christensson A, Laurell CB, and Lilja H: Enzymatic activity of the prostate specific antigen and its reactions with extra-cellular serine protease inhibitors. Eur J Biochem 194: 755-763, 1990.
3. 3. Lilja H, Christensson A, Dahlen U, et al: Prostate specific antigen in serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem 37: 1618-1625, 1991.
4. 4. Stenman UH, Leinonen J, Alfthan H, et al: A complex between prostate specific antigen and α-1-antichymotrypsin is the major form of prostate specific antigen in the serum of patients with prostate cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226, 1991.
5. 5. Christensson A, Bjork T, Nilsson O, et al: Serum prostate specific antigen complexed to a1-antichymotrypsin as an indicator of prostate cancer. J Urol 150: 100-105, 1993.
6. 6. Catalona WJ, Smith DS, Wolfert RL, et al: Evaluation of percentage of free serum prostate specific antigen to improve specificity of prostate cancer screening. J Am Med Assoc 274: 1214-1220, 1995.
7. 7. Luderer AA, Chen Y, Soriano TF, et al: Measurement of the proportion of free to total prostate specific antigen improves diagnostic performance of prostate specific antigen in the diagnostic gray zone of total prostate specific antigen. Urology 46: 187-194, 1995.
8. 8. Vashi AR, Wojno KJ, Henricks W, et al: Determination of the reflex range and appropriate cutpoints for percent free PSA in 413 men referred for prostatic evaluation using the AxSYM system. Urology 49: 19-27, 1997.
9. 9. Bangma CH, Rietbergen JB, Kranse R, et al: The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population. J Urol 157: 2191-2196, 1997.
10. 10. Sakr WA, Wheeler TM, Blute M, et al: Staging and reporting of prostate cancer - sampling of the radical prostatectomy specimen. Cancer 78: 366-368, 1996.
11. 11. Abrahamsson PA, Lilja H, and Oesterling JE: Molecular forms of serum PSA: the clinical value of percent free PSA. Urol Clin North Am 24: 353-366, 1997.
12. 12. Bjartell A, Bjork T, Matikainen MT, et al: Production of alpha-1-antichymotyrpsin by PSA-containing cells of the human prostate epithelium. Urology 42: 502-510, 1993.
13. 13. Bjork T, Bjartell A, Abrahamsson PA, et al: Alpha-1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign hyperplasia. Urology 43: 427-434, 1994.
14. 14. Vashi AR, Wojno KJ, Vessella RL, et al: Percent free PSA correlates directly with patient age. J Urol 157: 432A, 1997.
15. 15. Partin AW, Catalona WJ, Southwick PC, et al: Analysis of percent free prostate specific antigen for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology 48: 55-61, 1996.
16. 16. Haese A, Graefen M, Noldus J, et al: Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia. J Urol 158: 2188-2192, 1997.
17. 17. Oesterling JE, Jacobsen SJ, Klee CG, et al: Free, complexed and total serum PSA: the establishment of appropriate reference ranges for their concentrations and ratios. J Urol 154: 1090-1095, 1995.
18. 18. Yemoto CM, Nolley R, Prestigiacomo AF, et al: Free and total PSA density in patient with prostate cancer and benign prostatic hyperplasia. J Urol 155: 374A, 1996.
19. 19. Carter HB, Partin AW, Chan DW, et al: Percentage of free PSA in sera predicts cancer aggressiveness. J Urol 157: 444A, 1997.
20. 20. Arcanceli CG, Shephard DL, Smith DS, et al: Correlation of percent free PSA with pathologic features of prostatic carcinomas. J Urol 155: 415A, 1996.
21. 21. Pannek J, Subong EN, Jones KA, et al: The role of free/ total prostate specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer. Urology 48: 51-54, 1996.
22. 22. Henricks WH, England BG, Giacherio DA, et al: Serum percent free PSA does not predict extraprostatic spread of prostate cancer. Am J Clin Pathol 109: 533-539, 1998.
23. 23. Woodrum D, French C, and Shamel LB: Stability of free prostate specific antigen in serum samples under a variety of sample collection and sample storage conditions. Urology 48: 33-39, 1996.